Please Wait

Applying Filters...

Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Panobinostat lactate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 1 USDMF, 2 EU WC, 1 NDC API

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 3 FDA Orange Book

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 10MG BASE, CAPSULE;ORAL - EQ 15MG BASE, CAPSULE;ORAL - EQ 20MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 16 SPI Pharma, 3 Faran Shimi Pharmaceutical, 9 Gangwal Healthcare, 1 Pfanstiehl, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 2 DFE Pharma, 3 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 6 Kerry, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 15 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 27 Direct Compression, 15 Co-Processed Excipients, 14 Chewable & Orodispersible Aids, 13 Taste Masking, 12 Thickeners and Stabilizers, 10 Lubricants & Glidants, 9 Disintegrants & Superdisintegrants, 9 Granulation, 5 Controlled & Modified Release, 4 Parenteral, 3 Coating Systems & Additives, 1 Film Formers & Plasticizers, 1 API Stability Enhancers, 1 Rheology Modifiers, 1 Emulsifying Agents